Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L7VC
|
||||
| Former ID |
DNCL002225
|
||||
| Drug Name |
GI-6207
|
||||
| Indication | Metastatic medullary thyroid cancer [ICD9: 193; ICD10:C73] | Phase 1 | [524297] | ||
| Company |
GlobeImmune
|
||||
| Target and Pathway | |||||
| Target(s) | Carcinoembryonic antigen-related cell adhesion molecule 5 | Target Info | Modulator | [551895] | |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| References | |||||